FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ivan Montoya

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Geographic Areas

Activities & Behaviors

Patient Compliance

Living Beings

Psychiatry

Co-author Network

Publications

TOP 3
Roberta Kahn; Frances McSherry; Ivan Montoya; Cristin Murtaugh; Jill Williams; Elmer Yu; Elbert D Glover; Liza Gorgon; Thomas Jackson; Karen Jones; Robert M Anthenelli; Ahmed Elkashef
Selegiline transdermal system (STS) as an aid for smoking cessation.
Frank J Vocci; Ivan Montoya
Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence.
Tomas Drgon; Ivan Montoya; Catherine Johnson; Qingrong Liu; Donna Walther; Dean Hamer; George R. Uhl
Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ivan Montoya (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Roberta Kahn; Frances McSherry; Ivan Montoya; Cristin Murtaugh; Jill Williams; Elmer Yu; Elbert D Glover; Liza Gorgon; Thomas Jackson; Karen Jones; Robert M Anthenelli; Ahmed Elkashef
Selegiline transdermal system (STS) as an aid for smoking cessation.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2012;14(3):377-82.
2009: Frank J Vocci; Ivan Montoya
Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence.
Current opinion in psychiatry 2009;22(3):263-8.
2009: Tomas Drgon; Ivan Montoya; Catherine Johnson; Qingrong Liu; Donna Walther; Dean Hamer; George R. Uhl
Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers.
Molecular medicine (Cambridge, Mass.) 2009;15(1-2):21-7.
2008: Ivan Montoya; Frank Vocci
Novel medications to treat addictive disorders.
Current psychiatry reports 2008;10(5):392-8.
2008: Elmer Yu; Karen Miotto; Evaristo Akerele; Ann Montgomery; Ahmed Elkashef; Robert Walsh; Ivan Montoya; Marian W Fischman; Joseph F Collins; Frances McSherry; Kathy Boardman; David K Davies; Charles P O'Brien; Walter Ling; Herbert Kleber; Barbara H Herman
A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.
Drug and alcohol dependence 2008;97(1-2):158-68.
2008: Ivan Montoya
[Immunotherapies for drug addictions].
Adicciones 2008;20(2):111-5.
2006: Martha Velez; Ivan Montoya; Lauren M Jansson; Vickie Walters; Dace S. Svikis; Hendrée E Jones; Howard D Chilcoat; Jacquelyn C Campbell
Exposure to violence among substance-dependent pregnant women and their children.
Journal of substance abuse treatment 2006;30(1):31-8.
2005: Ivan Montoya; Diane M Herbeck; Dace S. Svikis; Harold Alan Pincus
Identification and treatment of patients with nicotine problems in routine clinical psychiatry practice.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2005;14(5):441-54.
2005: Douglas M Ziedonis; David A Smelson; Richard N Rosenthal; Steven L Batki; Alan I Green; Renata J Henry; Ivan Montoya; Joseph Parks; Roger D Weiss
Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.
Journal of psychiatric practice 2005;11(5):315-39.
2005: Diane M Herbeck; Diana J Fitek; Dace S. Svikis; Ivan Montoya; Steven C Marcus; Joyce C West
Treatment compliance in patients with comorbid psychiatric and substance use disorders.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2005;14(3):195-207.
2005: Ivan Montoya; Jennifer R Schroeder; Kenzie L. Preston; LINO COVI; ANNIE UMBRICHT; Carlo Contoreggi; Paul J Fudala; Rolley E. Johnson; David A Gorelick
Influence of psychotherapy attendance on buprenorphine treatment outcome.
Journal of substance abuse treatment 2005;28(3):247-54.
2005: Itzhak Levav; Robert Kohn; Ivan Montoya; Carlos Palacio; Pablo Rozic; Ida Solano; Willians Valentini; Benjamin Vicente; Jorge Castro Morales; Francisco Espejo Eigueta; Yamini Saravanan; Claudio T Miranda; Norman Sartorius
Training Latin American primary care physicians in the WPA module on depression: results of a multicenter trial.
Psychological medicine 2005;35(1):35-45.
2004: Martha Velez; Lauren M Jansson; Ivan Montoya; Wendy Schweitzer; Archie Golden; Dace S. Svikis
Parenting knowledge among substance abusing women in treatment.
Journal of substance abuse treatment 2004;27(3):215-22.
2004: Robert Forman; Dace S. Svikis; Ivan Montoya; Jack Blaine
Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network.
Journal of substance abuse treatment 2004;27(1):1-8.
2004: Ivan Montoya; David A Gorelick; Kenzie L. Preston; Jennifer R Schroeder; ANNIE UMBRICHT; Lawrence J Cheskin; W Robert Lange; Carlo Contoreggi; Rolley E. Johnson; Paul J Fudala
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence.
Clinical pharmacology and therapeutics 2004;75(1):34-48.
2003: David W Brook; Judith S Brook; Zohn Rosen; Mario De La Rosa; Ivan Montoya; Martin Whiteman
Early risk factors for violence in Colombian adolescents.
The American journal of psychiatry 2003;160(8):1470-8.
2003: Ivan Montoya; Diane M Herbeck; Dace S. Svikis; Diana J Fitek; Steven C Marcus; Harold Alan Pincus
Demographic and practice characteristics of psychiatrists who primarily treat patients with substance use disorders.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2003;12(3):181-92.
2002: David W Brook; Judith S Brook; Tine Pahl; Ivan Montoya
The longitudinal relationship between drug use and risky sexual behaviors among colombian adolescents.
Archives of pediatrics & adolescent medicine 2002;156(11):1101-7.
2002: Bethany A. Dipaula; Robert Schwartz; Ivan Montoya; David Barrett; Cecilia Tang
Heroin detoxification with buprenorphine on an inpatient psychiatric unit.
Journal of substance abuse treatment 2002;23(3):163-9.
2002: David W Brook; Judith S Brook; Zohn Rosen; Ivan Montoya
Correlates of marijuana use in Colombian adolescents: a focus on the impact of the ecological/cultural domain.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2002;31(3):286-98.
2002: Ivan Montoya; Kenzie L. Preston; Richard Rothman; David A Gorelick
Open-label pilot study of bupropion plus bromocriptine for treatment of cocaine dependence.
The American journal of drug and alcohol abuse 2002;28(1):189-96.
2001: Judith S Brook; David W Brook; Mario De La Rosa; Martin Whiteman; E Johnson; Ivan Montoya
Adolescent illegal drug use: the impact of personality, family, and environmental factors.
Journal of behavioral medicine 2001;24(2):183-203.
2000: R Escobar; A Rios; Ivan Montoya; Francisco Lopera; D Ramos; C Carvajal; G Constain; J E Gutierrez; S Vargas; C P Herrera
Clinical and cerebral blood flow changes in catatonic patients treated with ECT.
Journal of psychosomatic research 2000;49(6):423-9.
2000: Ivan Montoya; Dace S. Svikis; Steven C Marcus; A Suarez; Terri L Tanielian; H A Pincus
Psychiatric care of patients with depression and comorbid substance use disorders.
The Journal of clinical psychiatry 2000;61(9):698-705; quiz 706.
2000: G W Hall; NJ Carriero; R Y Takushi; Ivan Montoya; Kenzie L. Preston; David A Gorelick
Pathological gambling among cocaine-dependent outpatients.
The American journal of psychiatry 2000;157(7):1127-33.
1999: ANNIE UMBRICHT; Ivan Montoya; Donald R Hoover; K L Demuth; C T Chiang; Kenzie L. Preston
Naltrexone shortened opioid detoxification with buprenorphine.
Drug and alcohol dependence 1999;56(3):181-90.
1999: R Aszalos; David R McDuff; Eric Weintraub; Ivan Montoya; Robert Schwartz
Engaging hospitalized heroin-dependent patients into substance abuse treatment.
Journal of substance abuse treatment 1999;17(1-2):149-58.
1999: Judith S Brook; David W Brook; Mario De La Rosa; Martin Whiteman; Ivan Montoya
The role of parents in protecting Colombian adolescents from delinquency and marijuana use.
Archives of pediatrics & adolescent medicine 1999;153(5):457-64.
1999: Kenzie L. Preston; Kenneth Silverman; ANNIE UMBRICHT; A DeJesus; Ivan Montoya; Charles R Schuster
Improvement in naltrexone treatment compliance with contingency management.
Drug and alcohol dependence 1999;54(2):127-35.
1999: RP Schwartz; Robert K Brooner; Ivan Montoya; Marian Currens; Michael Hayes
A 12-year follow-up of a methadone medical maintenance program.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 1999;8(4):293-9.
1998: Kenneth Silverman; Conrad Jung Liang Wong; A Umbricht-Schneiter; Ivan Montoya; Charles R Schuster; Kenzie L. Preston
Broad beneficial effects of cocaine abstinence reinforcement among methadone patients.
Journal of consulting and clinical psychology 1998;66(5):811-24.
1998: Ivan Montoya
Charitable care and the nonprofit paradigm.
Journal of healthcare management / American College of Healthcare Executives 1998;43(5):416-24; discussion 425-6.
1998: Kenzie L. Preston; Kenneth Silverman; S T Higgins; Robert K Brooner; Ivan Montoya; Charles R Schuster; Edward J Cone
Cocaine use early in treatment predicts outcome in a behavioral treatment program.
Journal of consulting and clinical psychology 1998;66(4):691-6.
1998: Judith S Brook; David W Brook; Mario De La Rosa; Luis F Duque; E Rodriguez; Ivan Montoya; Martin Whiteman
Pathways to marijuana use among adolescents: cultural/ecological, family, peer, and personality influences.
Journal of the American Academy of Child and Adolescent Psychiatry 1998;37(7):759-66.
1998: David A Gorelick; Ivan Montoya; E O Johnson
Sociodemographic representation in published studies of cocaine abuse pharmacotherapy.
Drug and alcohol dependence 1998;49(2):89-93.
1996: Ivan Montoya; Howard D Chilcoat
Epidemiology of coca derivatives use in the Andean region: a tale of five countries.
Substance use & misuse 1996;31(10):1227-40.
1996: Kenneth Silverman; Conrad Jung Liang Wong; S T Higgins; Robert K Brooner; Ivan Montoya; C Contoreggi; A Umbricht-Schneiter; Charles R Schuster; Kenzie L. Preston
Increasing opiate abstinence through voucher-based reinforcement therapy.
Drug and alcohol dependence 1996;41(2):157-65.
1996: Kenneth Silverman; S T Higgins; Robert K Brooner; Ivan Montoya; Edward J Cone; Charles R Schuster; Kenzie L. Preston
Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.
Archives of general psychiatry 1996;53(5):409-15.
1996: A J Jenkins; T Llosa; Ivan Montoya; Edward J Cone
Identification and quantitation of alkaloids in coca tea.
Forensic science international 1996;77(3):179-89.
1996: W A Goodpastor; Ivan Montoya
Motivating physician behaviour change: social influence versus financial contingencies.
International journal of health care quality assurance 1996;9(6):4-9.
1995: Ivan Montoya; J M Hess; Kenzie L. Preston; David A Gorelick
A model for pharmacological research-treatment of cocaine dependence.
Journal of substance abuse treatment 1995;12(6):415-21.
1995: Ivan Montoya; ANNIE UMBRICHT; Kenzie L. Preston
Buprenorphine for human immunovirus-positive opiate-dependent patients.
Biological psychiatry 1995;38(2):135-6.
1995: Ivan Montoya; F R Levin; Paul J Fudala; David A Gorelick
Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence.
Drug and alcohol dependence 1995;38(3):213-9.
1995: Ivan Montoya; C Haertzen; J M Hess; LINO COVI; Paul J Fudala; Rolley E. Johnson; David A Gorelick
Comparison of psychological symptoms between drug abusers seeking and not seeking treatment.
The Journal of nervous and mental disease 1995;183(1):50-3.
1994: Ivan Montoya; C Haertzen
Reduction of psychopathology among individuals participating in non-treatment drug abuse residential studies.
Journal of addictive diseases 1994;13(2):89-97.